COVID-19 Vaccine Before or After Infection? For Super Immunity, It Makes No Difference
There are two routes to enhanced immune protection to SARS-CoV-2—breakthrough infections following vaccination and vaccination after natural infection.
Related Articles
Giant Virus That Infects Naegleria fowleri Isolated from Viennese Wastewater
A giant virus that replicates in the human pathogen single-celled organism Naegleria fowleri has been discovered.
Revealing Protein-Ligand Interactions Using AI Enables Drug Discovery
Researchers developed a method to assess the ability of small molecules to bind to hundreds of human proteins using AI and ML.
Neurons Disrupt Metabolism Following Spinal Cord Injury
Researchers discovered in mice that conditions such as diabetes diagnosed in people with spinal cord injuries, can be linked to abnormal post-injury neuronal activity.
Online Event
New tools and platforms to accelerate vaccine development and manufacturing are in high demand and short supply. InDevR’s VaxArray Platform is a microarray-based system for…
In a First, Neurons from Rat Stem Cells Regenerate Brain Circuits in Mice
Two independent research teams have successfully regenerated mouse brain circuits in mice using neurons grown from rat stem cells.
SCG Cell Therapy and A*STAR Collaborate on Scalable GMP Manufacturing of Cellular Immunotherapies
SCG says it has developed in-house cGMP manufacturing capabilities to supply high-quality cell therapy products to patients.
Producing Commercial-Scale Plant-Based Protein with Genetic Engineering
And there are benefits of plant cell expression systems, notably their impact on the cost of goods sold (COGS).
Cell Therapy Startup Energized via Smarter Operations
A British-based cell therapy company is using smart operations to streamline its viral vector processing.
2025 Cell & Gene Therapy Reimbursement Outlook
CMS proposed Medicare’s CGT reimbursement policy matches Medicaid’s sickle cell disease policy, forming a unified government approach.
One Bacterium’s Jekyll and Hyde Sides
Prodigiosin applications extend from manufacturing pigment and environmental-control agent to antibiotic and potential oncology drug.